Schizophreniform Disorder
📧 Sign up to get email alerts when something new happens for Schizophreniform Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode [NA]
This completed clinical trial evaluated whether combining exercise with cognitive training improves cognitive and functional outcomes after …
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Prevention of Weight Gain in Early Psychoses [NA]
A completed clinical trial update examining strategies to prevent weight gain in individuals with early psychosis.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents [Phase 2]
Phase 2 study evaluating lurasidone in antipsychotic-naive or quasi-naive children and adolescents with schizophrenia-spectrum and mood diso…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Electronic Cigarettes in Smokers With Mental Illness [NA]
A completed clinical trial investigating electronic cigarettes in smokers with mental illness; the summary does not provide trial results.
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia) [NA]
A clinical trial (RISE) evaluating rehabilitation interventions for people with schizophrenia in Ethiopia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia [NA]
A ClinicalTrials.gov entry indicates the Family-Directed Cognitive Adaptation Program for individuals with schizophrenia has completed its s…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Omega-3 Dietary Supplements in Schizophrenia [NA]
The clinical trial evaluating omega-3 dietary supplements for schizophrenia has completed and its results were posted in February 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Open-label Ziprasidone Study for Psychosis Treatment in Adolescents [Phase 3]
This open-label Phase 3 trial evaluated ziprasidone for treating psychosis-related disorders in adolescents, including schizophreniform diso…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis [NA]
This ClinicalTrials.gov entry reports a completed study on multi-disciplinary treatment for patients experiencing a first episode of psychos…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen [NA]
This update notes the completed status of a substudy within the OPTIMISE trial at Copenhagen, focusing on optimization of treatment and mana…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Lifestyle Intervention for Diabetes and Weight Management in Psychosis [NA]
A completed clinical trial evaluating a lifestyle intervention for diabetes management and weight loss in individuals with psychotic disorde…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Effectiveness of Adherence Therapy for Schizophrenia [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial from The Hong Kong Polytechnic University evaluating the effectiveness of adherence therapy for schizophre…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode Psychosis [NA]
Clinical trial update comparing integrated treatment with standard treatment for first-episode psychosis, sponsored by Bispebjerg Hospital.
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: RCT of Methotrexate Added to Treatment As Usual in Schizophrenia [Phase 1]
A Phase 1 randomized trial assessed adding methotrexate to treatment as usual in schizophrenia and related disorders; the study has been com…
-
CLINICAL_TRIALS other · 2015-08-24Clinical Trial Update: Anticholinergic Burden in Schizophrenia [NA]
Clinical trial update indicates that the study on anticholinergic burden in schizophrenia has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Optimizing Response in Psychosis Study [Phase 4]
Phase 4 clinical trial update for an Optimizing Response in Psychosis study indicates the trial was terminated with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: A Definitive Estrogen Patch Study (ADEPT) [Phase 2]
A phase 2 clinical trial (ADEPT) evaluating an estrogen patch for schizophrenia and related disorders has completed. Results were posted in …
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Clinical Estradiol Trial in Women With Schizophrenia [Phase 2]
A Phase 2 clinical trial of estradiol in women with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia [Phase 4]
Phase 4 clinical trial exploring selective estrogen receptor modulators as a potential treatment for psychotic symptoms in schizophrenia; th…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia [Phase 4]
A Phase 4 trial evaluated the efficacy and safety of A-prexa compared with Zyprexa (olanzapine) in patients with schizophrenia-spectrum diso…
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia [Phase 4]
Phase 4 clinical trial explored the effects of pravastatin on cholesterol, inflammation, and cognition in individuals with schizophrenia and…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Association of Amisulpride Response in Schizophrenia With Brain Image [Phase 4]
A Phase 4 clinical trial update examining the association between brain imaging findings and response to amisulpride in schizophrenia and sc…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
This completed clinical trial evaluated body mass index and metabolic changes after switching from olanzapine, risperidone, or quetiapine to…
-
CLINICAL_TRIALS trial_result · 2013-11-12Clinical Trial Update: A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis [Phase 4]
A Phase 4 trial compared risperidone long-acting injection with an oral antipsychotic in early psychosis; results were posted in 2013 and in…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders [Phase 4]
Phase 4 clinical trial update reporting efficacy and safety of Risperidone long-acting injectable in schizophrenia-spectrum disorders.